DYRK3 and oral cavity squamous cell carcinoma: This knowledge opens new avenues for further research on the PAICS/DYRK3 axis as a potential therapeutic target and may ultimately contribute to the development of novel treatment strategies for patients with oral squamous cell carcinoma.